ASSESSING NEW DRUGS
نویسندگان
چکیده
منابع مشابه
Assessing the Benefit-Risk for New Drugs
The U.S. Food and Drug Administration (FDA) regulates which drugs can bemarketed in the U.S. as well as their label requirements. A congressionally authorized advisory committee process allows the FDA to receive input from outside experts on important regulatory decisions (1). Further, the advisory committee process enhances transparency by allowing the public, including health care professiona...
متن کاملAssessing suicidal risk with antiepileptic drugs
Recently, the US Food and Drug Administration issued an alert about an increased risk for suicidality during treatment with antiepileptic drugs (AEDs) for different indications, including epilepsy. We discuss the issue of suicide in epilepsy with special attention to AEDs and the assessment of suicide in people with epilepsy. It has been suggested that early medical treatment with AEDs might po...
متن کاملAssessing Neurotoxicity of Drugs of Abuse, 136
ACKNOWLEDGMENT This monograph is based on the papers and discussions from a technical review on " Assessing Neurotoxicity of Drugs of Abuse " held on May 20-21, 1991, in Bethesda, MD. The technical review was sponsored by the National Institute on Drug Abuse (NIDA). COPYRIGHT STATUS NIDA has obtained permission from the copyright holders to reproduce certain previously published material as not...
متن کاملNEW DRUGS DRUG NEWS NEW DRUGS H1N1 Influenza Virus Vaccines
NEW DRUGS H1N1 Influenza Virus Vaccines The FDA has approved four vaccines to protect the population against the 2009 pandemic H1N1 influenza virus. About 45 million doses should be available at 90,000 sites in October. The government has ordered 195 million doses. CSL Ltd., MedImmune LLC, Sanofi-Pasteur, and Novartis Vaccines/Diagnostics Ltd. are using the same processes to make the H1N1 vacci...
متن کاملNEW DRUGS NEW DRUGS Ferriprox Reduces Excess Iron
NEW DRUGS Ferriprox Reduces Excess Iron Deferiprone (Ferriprox, Apo-Pharma, Inc.) has been approved to treat iron overload resulting from blood transfusions in patients with thalassemia who have responded inadequately to previous chelation therapy. Thalassemia is a genetic blood disorder that causes anemia. Patients with thalassemia have excess iron levels from frequent blood transfusions, a se...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Anaesthesia
سال: 1976
ISSN: 0007-0912
DOI: 10.1093/bja/48.9.819